PDCD1 and cancer: In conclusion, the current meta-analysis suggests that rs2227981 and rs11568821 polymorphisms of PD-1 and the rs4143815 polymorphism of PD-L1 were associated with protection against cancer, while PD-1 rs7421861 polymorphism significantly increased cancer risk.